Version 2.77

Description

Delafloxacin (DLX), trade name Baxdela, is a fluoroquinolone antibacterial used to treat acute bacterial skin and skin structure infections (ABSSSIs), which include cellulitis and erysipelas, wound infections and major skin abscesses. DLX is active against a broad spectrum of microorganisms, including those resistant to other fluoroquinolones such as MRSA (methicillin-resistant Staphylococcus aureus), a major cause of hospital-acquired skin infections. PMID: 28356714 Source: Regenstrief LOINC

Basic Part Properties

Part Display Name
Delafloxacin
Part Type
Component (Describes the core component or analyte measured)
Created On
2018-02-23
Construct for LOINC Short Name
DLX

LOINC Terminology Service (API) using HL7® FHIR® Get Info

CodeSystem lookup
https://fhir.loinc.org/CodeSystem/$lookup?system=http://loinc.org&code=LP266270-0

Language Variants Get Info

Tag Language Translation
it-IT Italian (Italy) Delafloxacina
zh-CN Chinese (China) 德拉沙星
Synonyms: CAS 189279-58-1;1-(6-氨基-3,5-二氟-2-吡啶基)-8-氯-6-氟-1,4-二氢-7-(3-羟基-1-氮杂环丁基)-4-氧代-3-喹啉羧酸;1-(6-Amino-3,5-difluoropyridin-2-yl)-8-chloro-6-fluoro-7-(3-hydroxyazetidin-1-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid;ABT-492;WQ-3034
es-ES Spanish (Spain) Delafloxacina